Innova SARS-CoV-2 Antigen Rapid Qualitative Test performance characteristics have not been adequately established, presenting a risk of false results.
Related Posts
Best Brands Consumer Products, Inc. is voluntarily recalling two (2) finished product lots of The Mandalorian Hand Sanitizer Ethyl Alcohol…
Mylan Pharmaceuticals Inc., a Viatris company, is voluntarily recalling one batch of its Insulin Glargine (Insulin glargineyfgn) Injection, 100 units/mL…
The U.S. Food and Drug Administration (FDA) wants to increase awareness about the intended use of imaging software for intracranial…
Today, the FDA issued an emergency use authorization for the first COVID-19 diagnostic test that detects chemical compounds in breath…
FDA issued a final guidance that will help protect animal health by addressing need for access to certain compounded animal…
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. Original source: http://www.fda.gov/news-events/press-announcements/fda-roundup-april-15-2022
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. Original source: http://www.fda.gov/news-events/press-announcements/fda-roundup-april-5-2022
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. Original source: http://www.fda.gov/news-events/press-announcements/fda-roundup-april-1-2022
FDA is announcing it is requesting a total budget of $8.4 billion as part of the President’s fiscal year 2023…
Do not use high-level disinfection methods for reprocessing affected urological endoscopes from Karl Storz. Original source: http://www.fda.gov/medical-devices/letters-health-care-providers/update-change-reprocessing-methods-certain-karl-storz-urological-endoscopes-letter-health-care